Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Disease mechanisms

Topic: Genetics and APOE

Whether the nodal vulnerability in dementia is solely represented by changes in cellular abundance or attrition of cellular transcriptomic landscape attribute to that transition in aging brain is yet to uncover with minutiae. To understand this complication, we have analyzed two snRNA-seq data specific to (I) dorsolateral prefrontal cortex (DLPFC): A comprehensive study of cellular profiling among cognitively normal and pathological ageing and dementia (AD) brain, (II) occipital cortex (OC) in the context of Nasu Hakola disease along with a tissue level bulk RNA-seq data corresponds to temporal cortex. We pinpoint cellular subpopulations their proportional changes within the nodal points and their transcriptomic profiling. In DLPFC we observed alteration of mitochondrial and synaptic maintenance program in the pathological manifestation of disease. In OC we noticed depleted upper layer CUX2 neuron, PVALB and SST neurons on the contrary an enrichment of RORB and LAMP5 neurons with compromised metabolic states in the disease context. Glial populations are marked by representation of fibrous astrocyte, neuronal-supporting subpopulations associated with extracellular matrix remodeling programs. Proportional increment of intermediate myelinating oligodendrocyte and a decrease in mature myelinating subpopulation highlighted a compromised myelin repair attempt. In temporal cortex at tissue level we observed transcriptomic landscape adopted a neuroglial phenotypes in dementia brain. Cell-Chat analysis demonstrated a shift in cellular coordination towards glial population from neuron in NHD brain. A single cell-based drug reprofiling approach identified efatutazone and balaglitazone as broad-spectrum candidates for major cell types in occipital cortex, whereas major actionable biological targets belong to CDK subtypes and proteasome subunits. Overall, our findings imply cellular persistence do not necessarily substantiate molecular preservation, also the coexistence of cellular vulnerability alongside selective remodeling features, present a cellular framework on how to cope up with degenerative changes.

Key findings

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 13 of the 62 points it could be judged on, which is 21 of 100. Raw total 21 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 21 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 21 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 13 of the 62 points we could judge it on, which is 21 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (bioRxiv)
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 13 / 62 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 13 of the 62 points we could judge it on is 21 out of 100.
Total 21 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Roy, B., & Roy, P. K. (2026). Subtype-Selective Neuronal Vulnerability and Compensatory Neuroglial Remodeling in Human Cortical Dementia. bioRxiv. https://doi.org/10.64898/2026.10.03.756274

Vancouver

Roy B, Roy PK. Subtype-Selective Neuronal Vulnerability and Compensatory Neuroglial Remodeling in Human Cortical Dementia. bioRxiv. 2026. doi:10.64898/2026.10.03.756274.

BibTeX

@article{roy2026-2cee5949,
  author  = {Roy, B. and Roy, P. K.},
  title   = {{Subtype-Selective Neuronal Vulnerability and Compensatory Neuroglial Remodeling in Human Cortical Dementia}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.10.03.756274},
  url     = {https://doi.org/10.64898/2026.10.03.756274}
}

Related studies in Disease mechanisms

Similar studies

More on Disease mechanisms

See all studies in Disease mechanisms →